Beta Bionics, Inc. (BBNX)
19.42
-0.50
(-2.51%)
USD |
NASDAQ |
Sep 04, 16:00
19.41
-0.01
(-0.05%)
After-Hours: 20:00
Beta Bionics Total Assets (Quarterly) : 292.39M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 292.39M |
| March 31, 2026 | 304.42M |
| December 31, 2025 | 328.74M |
| September 30, 2025 | 330.05M |
| June 30, 2025 | 329.97M |
| March 31, 2025 | 338.02M |
| Date | Value |
|---|---|
| December 31, 2024 | 149.64M |
| September 30, 2024 | 96.94M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 110.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Enovis Corp. | 3.766B |
| Edwards Lifesciences Corp. | 13.87B |
| Intuitive Surgical, Inc. | 20.88B |
| Kewaunee Scientific Corp. | 178.31M |
| STAAR Surgical Co. | 475.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.02M |
| Shareholders Equity (Quarterly) | 256.37M |
| Debt to Equity Ratio | 0.0254 |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.01% |